Viemed Healthcare (VMD) Cash from Investing Activities (2018 - 2026)
Viemed Healthcare's (VMD) quarterly Cash from Investing Activities came in at -$5.5 million in Q1 2026, up 35.7% YoY from -$4.0 million in Q1 2025, and up 27.94% on a QoQ basis from -$7.6 million in Q4 2025.
Viemed Healthcare (VMD) Cash from Investing Activities (2018 - 2026) Analysis & Trends
Viemed Healthcare (VMD) has 9 years of Cash from Investing Activities data on file, last reported at -$5.5 million in Q1 2026.
- Quarterly Cash from Investing Activities rose 35.7% year-over-year to -$5.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$47.1 million (down 39.15% YoY) and the FY2025 annual result came in at -$50.2 million, down 63.41% from the prior year.
- Cash from Investing Activities improved to -$5.5 million in Q1 2026, from -$7.6 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$1.7 million in Q2 2025 to a low of -$32.3 million in Q3 2025.
- A 5-year average of -$9.6 million and a median of -$7.4 million in 2022 frame the typical range for Cash from Investing Activities.
- The widest YoY moves for Cash from Investing Activities: up 84.53% in 2025, down 549.97% in 2025.
- Tracing VMD's Cash from Investing Activities over 5 years: stood at -$7.4 million in 2022, then fell by 1.56% to -$7.5 million in 2023, then decreased by 22.75% to -$9.2 million in 2024, then advanced by 17.24% to -$7.6 million in 2025, then climbed by 27.94% to -$5.5 million in 2026.
- The last three Cash from Investing Activities figures came in at -$5.5 million (Q1 2026), -$7.6 million (Q4 2025), and -$32.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Viemed Healthcare | 328.34 Mn | 317.66 Mn | 45.05 Mn | -7.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.84 Mn |
| Jun 30, 2026 | -7.84 Mn |
| Mar 31, 2026 | -5.49 Mn |
| Mar 31, 2026 | -5.49 Mn |
| Dec 31, 2025 | -7.61 Mn |
| Dec 31, 2025 | -7.61 Mn |
| Sep 30, 2025 | -32.30 Mn |
| Sep 30, 2025 | -32.30 Mn |
| Jun 30, 2025 | -1.73 Mn |
| Jun 30, 2025 | -1.73 Mn |
| Mar 31, 2025 | -8.53 Mn |
| Mar 31, 2025 | -8.53 Mn |
| Dec 31, 2024 | -9.20 Mn |
| Dec 31, 2024 | -9.20 Mn |
| Sep 30, 2024 | -4.97 Mn |
| Sep 30, 2024 | -4.97 Mn |
| Jun 30, 2024 | -11.17 Mn |
| Jun 30, 2024 | -11.17 Mn |
| Mar 31, 2024 | -5.37 Mn |
| Mar 31, 2024 | -5.37 Mn |